Paula Onofre-Oliveira

Paula Onofre-Oliveira

Auto-generated profile, based on publicly available information

Paula Onofre-Oliveira

Program for Genetics and Genome Biology, Hospital for Sick Children, Toronto, Canada

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2022 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
ESEge Sarikaya
Ege Sarikaya
NSNesrin Sabha
Nesrin Sabha
JVJonathan Volpatti
Jonathan Volpatti
EPEmanuela Pannia
Emanuela Pannia
NMNika Maani
Nika Maani
JDJames J. Dowling
James J. Dowling
X-linked myotubular myopathy (XLMTM) is a severe monogenetic disorder of the skeletal muscle. It is caused by loss-of-expression/function mutations in the myotubularin (MTM1) gene. Much of what is known about the disease, as well as the treatment strategies, has been uncovered through experimentation in pre-clinical models, particularly the Mtm1 gene knockout mouse line (Mtm1 KO). Despite this understanding, and the identification of potential therapies, much remains to be understood about XLMTM disease pathomechanisms, and about the normal functions of MTM1 in muscle development. To lay the groundwork for addressing these knowledge gaps, we performed a natural history study of Mtm1 KO mice. This included longitudinal comparative analyses of motor phenotype, transcriptome and proteome profiles, muscle structure and targeted molecular pathways. We identified age-associated changes in gene expression, mitochondrial function, myofiber size and key molecular markers, including DNM2. Importantly, some molecular and histopathologic changes preceded overt phenotypic changes, while others, such as triad structural alternations, occurred coincidentally with the presence of severe weakness. In total, this study provides a comprehensive longitudinal evaluation of the murine XLMTM disease process, and thus provides a critical framework for future investigations.

10 January 2020 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
SFStephanie A. Fernandes
Stephanie A. Fernandes
CACamila F. Almeida
Camila F. Almeida
LSLucas S. Souza
Lucas S. Souza
MLMonize Lazar
Monize Lazar
POPaula Onofre-Oliveira
Paula Onofre-Oliveira
MVMariz Vainzof
Mariz Vainzof
X-linked myopathy with excessive autophagy (XMEA) is a genetic disease associated with weakness of the proximal muscles. It is caused by mutations in the VMA21 gene, coding for a chaperone that functions in the vacuolar ATPase (v-ATPase) assembly. Mutations associated with lower content of assembled v-ATPases lead to an increase in lysosomal pH, culminating in partial blockage of macroautophagy, with accumulation of vacuoles of undigested content. Here, we studied a 5-year-old boy affected by XMEA, caused by a small indel in the VMA21 gene. Detection of sarcoplasmic Lc3 (also known as MAP1LC3B)-positive vacuoles in his muscle biopsy confirmed an autophagy defect. To understand how autophagy is regulated in XMEA myogenesis, we used patient-derived muscle cells to evaluate autophagy during in vitro muscle differentiation. An increase in lysosomal pH was observed in the patient's cells, compatible with predicted functional defect of his mutation. Additionally, there was an increase in autophagic flux in XMEA myotubes. Interestingly, we observed that differentiation of XMEA myoblasts was altered, with increased myotube formation observed through a higher fusion index, which was not dependent on lysosomal acidification. Moreover, no variation in the expression of myogenic factors nor the presence of regenerating fibers in the patient's muscle were observed. Myoblast fusion is a tightly regulated process; therefore, the uncontrolled fusion of XMEA myoblasts might generate cells that are not as functional as normal muscle cells. Our data provide new evidence on the reason for predominant muscle involvement in the context of the XMEA phenotype. This article has an associated First Person interview with the first author of the paper.

31 March 2025 in Neuromuscular Disorders
Verified
Journal Article
Closed access
POPaula Onofre-Oliveira
Paula Onofre-Oliveira
LGLinda Groom
Linda Groom
CLChen Liang
Chen Liang
BCBelinda Cowling
Belinda Cowling
MGMohammad M. Ghahramani-Seno
Mohammad M. Ghahramani-Seno
JDJames J. Dowling
James J. Dowling